FDA Inspection
Blaine Labs IncBlaine Labs Inc – FDA Inspection, Aug 12, 2010
Record Details
This FDA Inspection record concerns Blaine Labs Inc, with an inspection on August 12, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Blaine Labs Inc
- Inspection Date
- August 12, 2010
- Product Type
- Drugs
View Company Profile
ID · eda42511-868f-4ab7-8a9e-4a40abe3ccc0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 676243
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
- 21 CFR 211.100(a)Approval and review of procedures
- 21 CFR 211.198(a)Complaints reviewed by Quality Control Unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blaine Labs Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 22, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| December 15, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2019 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| March 24, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Blaine Labs Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.